Company intelligence / Profile preview

Rivia

Ownership: Private
Employees: ~7
Development stage: Other

Overview

Rivia offers an AI-powered unified data and analytics platform that integrates fragmented clinical trial data from multiple sources into standardized formats. The system enables real-time analysis, visualization, and actionable insights for biopharma companies running clinical trials. Clients report significant improvements in decision-making speed, clarity of patient profiles, cross-site comparisons, and overall trial efficiency. The technology is especially valued during early-stage development but supports the full lifecycle of drug development.

Modalities: Platform supports all therapeutic modalities
Industry: Drug Discovery Services

Partnerships

Abcentra Therapeutics (client/testimonial)Alentis Therapeutics (client/testimonial)

Beyond the preview

Go deeper on Rivia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rivia.

Explore the full profile